Pharma Executives Aren’t Excited About Trump’s Plans to Ease FDA Regulation
U.S. President Donald Trump's vow to roll back government regulations at least 75% is causing anxiety for some pharmaceutical executives that a less robust Food and Drug Administration would make it harder to secure insurance coverage for pricey new medicines. More: http://fortune.com/2017/03/13/trump-fda-regulation-pharma/
